GLOBAL DIABETES SUMMIT
“CONQUERING DIABETES FRONTIERS WITH NEW DISCOVERIES AND TECHNOLOGIES”
November 29, 2007
Welcome Reception (Non-CME Accredited)
7:00 pm to 9:00 pm
November 30, 2007 - Morning Program - 7:30 am-12:00 pm
Introduction
Kwame Osei, MD, Ohio State University Medical Center
Welcome
Wiley W. "Chip" Souba, MD, ScD, MBA
Interim Senior Vice President and Executive Dean for Health Sciences
Interim CEO, Ohio State University Medical Center
Opening Remarks
Jean-Claude Mbanya MD, PhD Cameroon(Yaoundé), President Elect, International Diabetes Federation (IDF)
Pierre Lefebvre MD, PhD Belgium(Brussels), Immediate Past President, International Diabetes Federation (IDF)
Aaron Kowalski, MD, JDRF, Representative
M. Sue Kirkham, MD Vice President, Clinical Affairs, ADA (USA)
Plenary Session: I
Global Diabetes Pandemic In the New Millennium; Threat to Cardiovascular Health and World Economies
Moderator: Jean-Claude Mbanya, MD, PhD
Pierre Lefebvre MD, PhD Belgium(Brussels), Immediate Past President, International Diabetes Federation (IDF)
Symposium I
Integrative Physiology of Glucose Homeostasis: Collusion of Beta Cell, Skeletal Muscle, Liver and Adipose Tissue
Moderators: Dara Schuster, MD, USA (Columbus)
Ele Ferrannini, MD, Italy (Parma)
The Challenges of Understanding Beta Cell Function and Insulin Resistance in Patients with Type 2 Diabetes
Ele Ferrannini, MD, Italy (Parma)
The Pathogenesis of Diabetes and Prediabetes: Implications for Therapy
Robert Rizza, MD, USA (Rochester)
In vivo Integrated Assessment of Insulin Secretion and Insulin Action
What is the Best Approach ?
Richard Bergman, PhD, USA (Los Angeles)
Panel Discussion and Q/A
Ele Ferrannni, MD, PhD
Robert Rizza, MD
Richard Bergman, PhD
Symposium II
Physiology of Metabolic Syndrome: A New Look
Moderator: Naomi Lewitt, MB, BS, South Africa (Cape Town)
Insulin Resistance and Metabolic Syndrome: Why the Controversies?
David Kelley, MD, USA (Pittsburgh)
Significance of Metabolic Quartet: Are Adipocytokines the Key Players in Metabolic Syndrome?
Philipp Scherer, PhD, USA (Dallas)
Panel Discussion and Q/A
David Kelley, MD
Philipp Scherer, PhD
November 30, 2007 Afternoon Program 12:00-3:00 pm
Plenary Session II: Mini-Symposium and Lunch
Moderator:
Pierre Lefebvre, MD, PhD
The Global Trends and Faces of Diabetes: Strategies to Overcome the Diabetes Pandemic
Jean-Claude Mbanya, MD, PhD
Concurrent Workshops I
Workshop IA: Unique Faces of Diabetes in Special Ethnic Populations
Moderators: Enrique Caballero, MD, USA (Boston)
Ayesha Motala, MB, BS, S. Africa (Durban)
Diabetes in Asians
Ambady Ramachandran, MD, India (Madras)
Diabetes in West Africans
Albert Amoah, MB,BS, Ghana (Accra)
Diabetes in Latinos
Enrique Caballero, MD
Diabetes in South Africans
Naomi Lewitt , MB, BS, Africa (Cape Town)
Diabetes in Australian Aborigenese;
Ashim Sinha, MBBS, Australia (Cairns)
Workshop IB: Health Economics and Outcomes of New Surgical Technique in Diabetes
Moderators: Charles Cook, MD, USA (Columbus)
Scott Melvin, MD, USA (Columbus)
Minimal Invasive and Robotic Cardiac Surgery: Applications in Diabetic Patients
Benjamin Sun, MD, USA (Columbus)
Minimally Invasive Roux-en-Y Gastric Bypass Surgery for Obese Type 2 diabetics:: Is The Verdict In?
Bradley Needleman, MD, USA (Columbus)
Peripheral Vascular Disease in Diabetics: Application of Minimal Invasive Surgical Procedures
Patrick Vaccarro MD, USA (Columbus)
Wound Healing in Diabetics: Practical Insights Using New Technologies
Sashwati Roy, PhD, USA (Columbus)
Workshop 1C: Immunological Advances in Type 1 Diabetes
Moderators: Dana Hardin, MD, USA (Columbus)
Dorothy Becker, MD, USA ( Pittsburgh)
Genetics and Immunological / Environmental Triggers of Type 1 Diabetes
Dorothy Becker, MD
Strategies for Primary and Secondary Prevention of Type 1 Diabetes: Role of Immunological and Non-Immunological Modulators
Jay Skyler, MD, USA (Miami)
Effects of Immune Modulation in the Natural History of Type 1 Diabetes
Kevan Herold, MD, USA (New York)
Panel Discussion and Q/A
Kevan Herold, MD
Jay Skyler, MD
Dorothy Becker, MD
Workshop I D: Advances in Diabetic Nephropathy and Cardiovascular Diseases
Moderators: Lawrence Agodoa, MD USA (Bethesda) - National Institutes for Health
Alan Go, MD, USA (Oakland, CA)
Chronic Kidney Disease as a Risk Factor for Cardiovascular Diseases: Evidence on Mortality and Morbidity
Alan Go, MD
Screening for Diabetic Kidney Diseases: What is the Risk?
Hollie Kramer, MD, USA (Chicago)
Chronic Renal Diseases and Metabolic Syndrome: Are they Equivalent?
William McClellan, MD, USA (Atlanta)
Chronic Renal Disease as An Insulin-Resistant State: Special Considerations in Selecting ARBs and/or ACEIs
James Sowers, MD, USA (Missouri)
Afternoon Entertainment: Tour of Columbus and Ohio State University Medical Center (non CME accredited)
November 30, 2007 Special Evening Program 7:00pm - 9:30pm
Dinner Symposium
Remediable Risk Factors In The Emergence Of Global Cardio-Metabolic Pandemic
Moderators: George Mensah, MD USA (CDC, Atlanta)
Kwame Osei, MD USA (Columbus)
Global Cardiovascular Pandemic: The Role of Obesity and Modern Lifestyle
Sandeep Gupta, MD UK( London)
Diabetes and Cardiovascular Pandemic: Are they Coronary Equivalent
Stephen Haffner MD USA ( San Antonio)
Metabolic Syndrome and CHD: Strategies for Intervention
Robert Eckel MD USA (Denver)
Panel Discussion and Q/A
Sandeep Gupta, MD
Robert Eckel MD USA (Denver)
Stephen Haffner MD USA ( San Antonio)
George Mensah MD USA (CDC, Atlanta)
December 1, 2007 Morning Program 7:30am -12:00 noon
Plenary Session III: The Challenges of Diabetes in the New Millennium: USA Experience
Frank Vinicor, MD, USA (Atlanta) - Centers for Disease Control and Prevention
Symposium III: Epidemic of Childhood Diabetes: Challenges and Hopes
Moderators: Kaushik Ramaiya, MB, BS, Africa (Tanzania)
Abbas Kitbachi, MD USA (Tennessee)
Childhood and Youth Type 2 Ddiabetes: The Evolving Picture
Silva Arslarian, MD, USA (Pittsburgh)
Childhood Obesity and Type 2 Diabetes: Strategies for Early Intervention
Sonia Caprio, USA (New Haven)
Strategies in the Prevention of Diabetes Using Lifestyle Modification and Education: Hawaiian Experience
Abbas Kitbachi, MD
Panel Discussion and Q/A
Silva Arslarian, MD
Sonia Caprio, MD
Kaushik Ramaiya, MB, BS
Plenary Session IV: Symposium of Development of New Drug Therapies in Diabetes
Moderators: James Reed, MD, USA (Atlanta)
Bernard Zinman, MD, Canada (Toronto)
Exendin-4 and GLP-I Agonists: New Therapeutics for Diabetes
Alain Baron, MD, USA (San Diego)
DPP -4 Inhibitors: Effects on Diabetes Beta Cell Health and CVD Risks
John Buse, MD, USA (Columbia)
Unique Features of New Insulin Analogues: Pros and Cons for Early Intervention in Diabetes
Bernard Zinman, MD, Canada (Toronto)
Panel Discussion and Q/A
Alain Baron, MD
John Buse, MD
Bernard Zinman, MD
December 1, 2007 Afternoon Program 12:00pm -6:00pm
Moderator: Ashim Sinha, MB, BS, Australia (Cairns Straits)
Telemedicine in Diabetes Care Delivery: Bringing Diabetes Experts to Rural /Underserved Areas and Developing Countries
Ryan Spaulding, PhD, USA (Kansas)
Symposium IV: Evidence –Based Primary Prevention of Type 2 Diabetes
Sam Dagogo-Jack, MD, PhD, USA (Memphis)
Jaakko Tuomilehto, MD, Finland (Helsinki)
Approaches for the Effective Primary Prevention of Diabetes: Implications of DPP
Robert Ratner, MD, USA (Washington DC)
Lifestyle Approaches to Prevention of Type 2 Diabetes: Lessons From Finish Diabetes Prevention Study
Jaakko Tuomilehto, MD, Finland (Helsinki)
Pharmacological Approaches for Primary Prevention of Type 2 Diabetes: Lessons from TRIPOD and DREAM
Thomas Buchanan, MD, USA (Los Angeles)
Diabetes and Metabolic Syndrome in Africans: Rationale for Early Intervention
Ayesha Motala, MD, S. Africa (Durban)
Psychological Factors in Primary Prevention of Type 2 Diabetes
Richard Rubin, PhD, USA (Baltimore)
Concurrent Workshops II
Workshop IIA: Future of Islet Cell Transplantation and Cellular Therapies in Diabetes
Dedicated to the late Paul Lacy, PhD
Moderators: Amer Rajab, MD, PhD, USA (Columbus)
Jonathan Lakey, PhD, Canada (Edmonton)
2007 Annual Report: Collaborative Islet Cell Transplantation Registry
Rodolfo Alejandro, MD, USA (Miami)
Do’s and Don’t’s of Islet Cell Transplantation
Jonathan Lakey, PhD, Canada (Edmonton)
Consideration in Selection of Immunosuppressive Therapies in Islet Cell Transplantation and Cellular Therapies: NIH Experience
David Harlan, MD, USA (Washington, DC)
Imaging of Islet Cells: Application in Islet Cell and Pancreas Transplantation
Alvin Powers, MD, USA (Nashville)
Encapsulated Human- and Xeno-Islet Cell Transplantation: Obstacles and Promises
James Gavin III , MD, PhD, USA (San Diego)
WORKSHOP II B: Insulin Delivery and Glucose Sensing Technologies
Moderators: Aaron Kowalski, MD, USA (NY) - Juvenile Diabetes Research Foundation
Irl Hirsch, MD, USA (Seattle)
New Technologies in Insulin Delivery Systems in Diabetics
Alan Marcus, MD, USA (Los Angeles)
Closing the Loop: Current Status and Near-Term Future
Christopher Saudek, MD, USA (Baltimore)
Closing Insulin -Glucose Loop: Is Artificial Pancreas Really Necessary?
Barry Ginsberg, MD, USA (Bridgewater, NJ)
Noninvasive Glucose Monitoring Technologies: Potential Application in Hospitalized Patients?
Irl Hirsch, MD, USA (Seattle)
Panel Discussion and Q/A
Alan Marcus, MD
Barry Ginsberg, MD
Christopher Saudek, MD
Irl Hirsch, MD
WORKSHOP IIC: Diabetes in Pregnancy
Moderators: Douglas Kniss, PhD, USA (Columbus)
Mark Landon, MD, USA (Columbus)
Diabetes in Pregnancy: Predictors of Maternal-Fetal Outcomes
Lois Jovanovic, MD, USA( Santa Barbara)
Current Concepts in Gestational Diabetes: The Role of Adipocytokines
Patrick Catalano, MD, USA (Cleveland)
Practical Approaches to Effective Management of Diabetes in Pregnancy: Diet vs. Insulin vs Oral Antidiabetic Medications?
Mark Landon, MD, USA (Columbus)
Care of the Pregnancy Complicated by Diabetes Mellitus: The Application of New Technologies
Steven Gabbe, MD, USA ( Nashville)
Panel Discussion and Q/A
Lois Jovanovic, MD
Steven Gabbe, MD
Patrick Catalano, MD
Douglas Kniss, PhD
WORKSHOP IID: AADE
Diabetes Education Outcomes: The Journey from Standards to Outcomes
Donna Rice, RN, MBA, CDE USA (Michigan)
Malinda Peeples, RN, MS, CDE USA (Chicago)
Diabetes Education: Not Just Information but Behavior Change
Amparo Gonzalez RN, CDE (Chicago)
Marcia Draheim RN, CDE USA (Iowa)
Panel Discussion and Q/A
Donna Rice, RN, MBA, CDE; Malinda Peeples, RN, MS, CDE
Ampara Gonzalez, RN, CDE; Marcia Draheim, RN, CDE
December 1, 2007 Evening Program 6:30pm- 11:00pm
Dinner Symposium: Pharmacological Approaches for Primary Prevention Obesity, Diabetes and Cardiovascular Diseases
Moderators: Kenneth Jamerson, MD, USA (Ann Arbor)
F. Xavier Pi-Sunyer, MD, USA (New York)
Role of New PPAR Agonists in Diabetes and Cardiovascular Diseases: Outcome Studies
Willa Hsueh, MD, USA (Los Angeles)
Endocannabinoid System in Metabolic Syndrome: What is the Evidence?
George Bray, USA ( Baton Rouge)
Future of Endocannabinoids in Cardiovascular Diseases: Will They Become a Reality?
F. Xavier Pi-Sunyer, MD, USA (New York)
Closing Comments and Adjournment
Evening Entertainment (Non-CME Accredited)
